- $1.75bn
- $1.65bn
- $6.50m
Annual cashflow statement for Anterix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.5 | -16.3 | -9.13 | -11.4 | 90.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.58 | -19.8 | -25.3 | -25.9 | -128 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 49.4 | 6.24 | 74.8 | 7.14 | 42.6 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 17.9 | -27.3 | 42 | -29.3 | 5.51 |
| Capital Expenditures | -27.4 | -27.1 | -17.3 | -18.2 | -27.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 25.4 | 40.9 | 67.7 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -27.4 | -27.1 | 8.09 | 22.8 | 40.5 |
| Financing Cash Flow Items | -1.46 | -1.56 | -1.24 | -1.84 | -0.77 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -2.42 | -8.06 | -25.1 | -6.59 | 3.59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.9 | -62.4 | 24.9 | -13.1 | 49.6 |